RARE - Ultragenyx Pharmaceutical Inc.
NEXT EARNINGS:
Feb 12, 2026
(in 5 days)
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$51.57
DETAILS
HIGH:
$63.00
LOW:
$44.00
MEDIAN:
$50.00
CONSENSUS:
$51.57
UPSIDE:
108.79%
Market Cap:
2.38B
Volume:
2,518,158
Avg Volume:
2,471,608
52 Week Range:
18.41-46.27
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.15
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
1,294
IPO Date:
2014-01-31
EPS (TTM):
-6.29
P/E Ratio:
-6.69
Revenue (TTM):
560.23M
Total Assets:
1.50B
Total Debt:
40.34M
Cash & Equiv:
173.73M
Rev Growth (5Y):
40.1%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-43.5%
Debt/Equity:
0.16
Track Record
Statements >| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 560.23M | 434.25M | 363.33M | 351.41M | 271.03M | 103.71M | 51.49M | 2.61M | 133,000 | N/A | N/A | N/A |
| Net Income | (569.18M) | (606.64M) | (707.42M) | (454.02M) | (186.57M) | (402.73M) | (197.61M) | (302.14M) | (245.87M) | (145.62M) | (59.80M) | (35.07M) |
| EPS | -6.29 | -8.25 | -10.12 | -6.70 | -3.07 | -7.12 | -3.97 | -7.12 | -6.21 | -3.96 | -2.08 | -1.21 |
| Total Assets | 1.50B | 1.49B | 1.55B | 1.52B | 1.76B | 1.14B | 719.56M | 490.75M | 540.63M | 559.57M | 197.97M | 59.65M |
| Total Debt | 40.34M | 43.17M | 31.59M | 41.97M | 48.23M | 36.99M | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | 173.73M | 213.58M | 132.94M | 307.58M | 713.53M | 433.58M | 113.43M | 100.49M | 161.12M | 93.57M | 24.32M | 7.43M |
| Operating Cash Flow | (414.19M) | (474.81M) | (380.46M) | (338.69M) | (132.22M) | (345.38M) | (290.57M) | (253.84M) | (160.97M) | (105.98M) | (44.63M) | (31.20M) |
| Free Cash Flow | (421.68M) | (521.57M) | (526.59M) | (411.79M) | (176.12M) | (370.21M) | (294.64M) | (256.64M) | (171.16M) | (110.93M) | (46.78M) | (31.61M) |
| FCF per Share | -4.66 | -7.09 | -7.53 | -6.07 | -2.89 | -6.54 | -5.92 | -6.05 | -4.32 | -3.02 | -1.63 | -1.09 |
| Book Value | 255.30M | 275.41M | 352.49M | 922.56M | 1.15B | 653.76M | 608.91M | 383.45M | 473.97M | 531.09M | 184.94M | 50.11M |
| Cash & ST Investments | 610.02M | 577.21M | 747.76M | 740.20M | 1.20B | 755.23M | 459.71M | 244.47M | 498.11M | 437.00M | 187.49M | 53.38M |
| ROC Equity | -2.23 | -2.20 | -2.01 | -0.49 | -0.16 | -0.62 | -0.32 | -0.79 | -0.52 | -0.27 | -0.32 | -0.70 |